Y Mabs Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.2M | 170k | 6.82 |
| 2023-09-30 | $1.0M | 184k | 5.45 |
| 2023-06-30 | $1.3M | 186k | 6.79 |
| 2023-03-31 | $872k | 174k | 5.01 |
| 2022-12-31 | $834k | 171k | 4.88 |
| 2022-09-30 | $632k | 44k | 14.41 |
| 2022-06-30 | $545k | 36k | 15.12 |
| 2022-03-31 | $314k | 26k | 11.87 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management